logo Kompas.id
EnglishGreater Jakarta’s Specificity
Iklan

Greater Jakarta’s Specificity

The COVID-19 outbreak in Greater Jakarta requires special treatment due to the nature of Jakarta and its buffer cities with its high level of mobility.

By
KOMPAS EDITOR
· 3 minutes read
https://cdn-assetd.kompas.id/V9DqYNnccVfZeB5h-fJSmd3pELk=/1024x682/filters:watermark(https://cdn-content.kompas.id/umum/kompas_main_logo.png,-16p,-13p,0)/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2020%2F08%2F20200806TAM05_1597073886.jpg
KOMPAS/TATANG MULYANA SINAGA

A member of the research team for the Covid-19 vaccine clinical trial runs a series of health checks to screen a volunteer on Thursday (6/8/2020) at the School of Medicine, Padjadjaran University (Unpad) in the city of Bandung, West Java. The clinical trial of the candidate vaccine produced by Sinovac, China, began on Tuesday (11/8/2020) at six locations: the Unpad Education Hospital, the Unpad Health Center and four puskesmas (community health centers) in the city.

The COVID-19 outbreak in Greater Jakarta requires special treatment due to the nature of Jakarta and its buffer cities with its high level of mobility.

Jakarta as the nation’s capital, is not only the seat of the national government and a major business hub. For decades, Jakarta has attracted people seeking better lives. Understandably, tens of millions of people from Bogor, Depok, Tangerang and Bekasi (Bodetabek), the capital’s buffer zones, go to the capital every day to earn their livelihood.

Editor:
Syahnan Rangkuti
Share
Logo Kompas
Logo iosLogo android
Kantor Redaksi
Menara Kompas Lantai 5, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 5347 710
+6221 5347 720
+6221 5347 730
+6221 530 2200
Kantor Iklan
Menara Kompas Lantai 2, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 8062 6699
Layanan Pelanggan
Kompas Kring
+6221 2567 6000